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Abstract
Shifts between epigenetic states of transcriptional activity are typically correlated with changes in epigenetic marks.
However, exceptions to this rule suggest the existence of additional, as yet uncharacterized, layers of epigenetic regulation.
MOM1, a protein of 2,001 amino acids that acts as a transcriptional silencer, represents such an exception. Here we define
the 82 amino acid domain called CMM2 (Conserved MOM1 Motif 2) as a minimal MOM1 fragment capable of transcriptional
regulation. As determined by X-ray crystallography, this motif folds into an unusual hendecad-based coiled-coil. Structure-
based mutagenesis followed by transgenic complementation tests in plants demonstrate that CMM2 and its dimerization
are effective for transcriptional suppression at chromosomal loci co-regulated by MOM1 and the siRNA pathway but not at
loci controlled by MOM1 in an siRNA–independent fashion. These results reveal a surprising separation of epigenetic
activities that enable the single, large MOM1 protein to coordinate cooperating mechanisms of epigenetic regulation.
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Introduction
Transcriptional gene silencing (TGS) refers to the stable
repression of transcription and mainly affects transposons,
chromosomal repeats and transgenic inserts; however, it may also
suppress the expression of certain protein-coding genes. In
multicellular eukaryotes, TGS can persist through mitotic divisions
and also be inherited meiotically, which is especially well
documented for plants. Such TGS stability is achieved by the
concerted action of multiple epigenetic mechanisms that establish
and maintain particular patterns of covalent modification of DNA
and histone proteins throughout DNA replication [1]. For
example, local hypermethylation of cytosines accompanied by
repressive marks on histones, such as di-methylation of histone H3
at lysine in position 9 (H3K9me2), shifts chromatin structure into a
repressive conformation and results in TGS. Conversely,
decreased levels or loss of cytosine methylation (
mC) and
H3K9me2 release silencing [1].
In plants,
mC occurs in two classes of sequence context; CG and
non-CG. CG methylation (
mCG) is propagated by the DNA
methyltransferase MET1 in cooperation with SRA domain
proteins, which use newly replicated, hemi-methylated DNA as
template [2–5]. Non-CG methylation can be further subdivided
into
mCHG and
mCHH (where H stands for C, A or T)
maintained by two additional DNA methyltransferases: CMT3
and DRM2, respectively. CMT3 uses the H3K9me2 mark for
methylation targeting [6–8], while DRM2 is recruited to its targets
by siRNAs in an RNA-directed DNA methylation (RdDM)
process [9].
mCHG and H3K9me2 are interlinked by a complex
regulatory loop [10] in which the H3K9 histone methyltransferase
SUVH4/KYP uses CHG methylation for targeting and creates
H3K9me2-rich domains attracting CMT3 [11–13]. Moreover,
global reduction of cytosine methylation in met1 mutants causes
redistribution of H3K9me2 and release of TGS [14–16].
Arabidopsis MORPHEUS’ MOLECULE1 (MOM1) is an
exceptional TGS regulator that acts largely independently of
changes in the levels of DNA methylation and H3K9me2. In mom1
mutants, although TGS is released at transposons, repetitive
sequences and transgenes, silencing release occurs in this case
without major alterations in DNA or histone modification, as is the
case for the mutation of genes necessary for maintenance of
cytosine and histone methylation [17–21]. Therefore, MOM1
appears to control TGS using different, as yet not well-understood
molecular mechanisms. The results from recent studies on genetic
modifiers of the mom1 mutation suggest that MOM1 acts
downstream of RdDM-mediated cytosine methylation [22,23].
However, this occurs only at a subset of loci subjected to MOM1-
mediated regulation; TGS activity at other loci was either
independent of RdDM, or MOM1 was able to modify the activity
of RdDM (enhancing or suppressing) [23]. Thus, these results
reveal complex cooperation between MOM1 and the RdDM in
the regulation of TGS, dividing their common target loci into
PLoS Genetics | www.plosgenetics.org 1 February 2012 | Volume 8 | Issue 2 | e1002484several categories according to their independence or cooperation
with MOM1 and RdDM-mediated regulation [23]. In addition,
the preferential targets for MOM1-mediated TGS are loci
associated with intermediate levels of both H3K9me2 and
H3K4me2, which marks transcriptionally active chromatin [20].
Interestingly, at one particular locus targeted by RdDM,
SUPPRESSOR OF drm1 drm2 cmt3 (SDC), H3K9me2 levels
decreased in mom1 mutants, suggesting that MOM1 is involved
in the transduction of RdDM signals to H3K9me2 marks at the
SDC gene [22]. The results from these previous studies all point
towards several distinct mechanisms of MOM1-mediated TGS
that appear to be executed according to epigenetic marks on the
target loci, in cooperation with further epigenetic regulatory
mechanisms.
MOM1 is a large nuclear protein of 2001 amino acids
containing an incomplete and highly degenerate helicase domain
related to a similar domain found in CHD3 chromatin-remodeling
factors [17,24]. However, functional studies of MOM1 deletions
showed this fraction of the protein to be dispensable for its TGS
activity [24]. Surprisingly, only the predicted nuclear localization
signal (NLS) and a short fragment of MOM1 of less than 200
amino acids (1663 to 1859) containing a conserved plant-specific
motif of 82 amino acids (1734 to 1815), named Conserved MOM1
Motif 2 (CMM2), is required for TGS activity [24]. CMM2 is
found in MOM1 homologues of all vascular plants for which
genome sequences are available. This implies that the CMM2
domain plays a crucial role in TGS regulation in most land plants;
however, the molecular mechanism of CMM2-mediated silencing
remains obscure.
Here we present the crystal structure of the CMM2 domain and
the results of in vivo studies that indicate the importance of CMM2
homo-multimerization for its TGS activity. The structural analyses
uncover intermolecular interactions between CMM2 domains via
the formation of an anti-parallel coiled-coil structure and suggest
the formation of multimers. Testing these predictions in vivo,w e
have confirmed that CMM2 interactions do occur and are
essential for the CMM2-mediated activity in TGS. Moreover, we
found that, although CMM2 was able to mediate TGS at loci
regulated by MOM1 in cooperation with RdDM, CMM2
silencing activity was compromised at loci controlled by MOM1
in an RdDM-independent fashion. The analysis of MOM1
mutants with a disrupted CMM2 intermolecular interface in
transgenic plants revealed that CMM2 intermolecular interactions
are necessary and largely sufficient for TGS regulation at loci that
are also regulated by RdDM. However, for the initiation and/or
maintenance of TGS at loci not controlled by RdDM, the coiled-
coil forming CMM2 domain is only partially effective. Thus,
further elements of MOM1, or possibly the entire protein, are
required here for stabilization of TGS. Thus, our results provide a
molecular framework for understanding how MOM1 mediates
TGS.
Results
The CMM2 domain is necessary and sufficient for
silencing of a transgenic locus
Previously reported functional mapping of the MOM1 protein
demonstrated that a short fragment of the protein containing
CMM2, known as miniMOM1 (Figure 1A), was necessary and
sufficient for TGS [24]. Although these results strongly suggested
that CMM2 is the crucial domain for the TGS activity of MOM1,
a contribution to the silencing activity of miniMOM1 regions
adjacent to CMM2 (N- terminal amino acids 1663 to 1733, and C-
terminal amino acids 1816 to 1859) (Figure 1B) could not be ruled
out [24]. To address more precisely the TGS activity of the
CMM2 domain only, we removed fragments of miniMOM1
flanking CMM2 and performed transgenic complementation
assays for restoration of TGS in mom1 mutant plants (Figure 1B
and 1C). As readout, we used the well-characterized transgenic
locus coding for ß-glucuronidase (GUS), which is known to be
silenced by TGS (L5 line [25]). Transcription of this locus was
restored in mom1 mutants and the GUS activity visualized by
histochemical staining (mom1L5 line [17,24]). In the case of
functional complementation of the mom1 mutation, the GUS locus
was re-silenced and its transcript and GUS activity vanished.
To monitor GUS activity, we stained cotyledons of seven T1
transgenic plants obtained with each complementation construct
(Figure 1B). The original miniMOM1 construct suppressed GUS
activity, confirming the previous observations (Figure 1B, ‘‘mini-
MOM1’’; [24]). The GUS gene remained active in transgenic
plants with chromosomal integrations of the empty expression
cassette (Figure 1B, ‘‘empty vector’’). Incorporation of mini-
MOM1 fragments flanking CMM2 into the expression cassette
had no influence on GUS activity, suggesting that these parts of
miniMOM1 have no TGS activity of their own (Figure 1B,
DCMM2, C’’ and ‘‘DN,CMM2’’ constructs). Consistently, dele-
tions of these regions from miniMOM1 (Figure 1B, ‘‘DC’’ and
‘‘DN’’ constructs) did not affect TGS efficiency. Finally, we
assessed the TGS activity of the CMM2 domain itself (Figure 1B
‘‘DN,C’’ construct) and found a somewhat variable degree of mom1
complementation, with three transgenic plants displaying a high
degree of complementation (Figure 1B, plants 1, 2, 7), three with
incomplete complementation (Figure 1B, plants 3, 4, 6) and one
with no indication of complementation (Figure 1B, plant 5).
To better quantify the TGS activity of miniMOM1 derivatives
and especially of the CMM2 domain alone, we performed
quantitative RT-PCR analyses. For each construct, we examined
the T2 progeny of three randomly chosen T1 plants (Figure 1C).
‘‘miniMOM1’’, ‘‘DC’’ and ‘‘DN’’ complemented the mom1
mutation and suppressed GUS transcription (Figure 1C), confirm-
ing the results from our histochemical analyses. Also consistent
with the GUS staining results, deletion of CMM2 abolished TGS
Author Summary
Epigenetic shifts in transcriptional activities are usually
correlated with changes in chromatin properties and
covalent modification of DNA and/or histones. There are,
however, exceptional regulators that are able to switch
epigenetic states without the apparent involvement of
changes in chromatin or DNA modifications. MOM1
protein, derived from CHD3 chromatin remodelers, be-
longs to this group. Here we defined a very small domain
of MOM1 (less than 5% of its total sequence) that is
sufficient for epigenetic regulation. We solved the
structure of this domain and found that it forms a dimer
with each monomer consisting of unusual consecutive 11
amino-acid hendecad repeats folding into an antiparallel
coiled-coil. In vivo experiments demonstrated that the
formation of this coiled-coil is essential for silencing
activity; however, it is effective only at loci co-silenced by
MOM1 and small RNAs. At loci not controlled by small
RNAs, the entire MOM1 protein is required. Our results
demonstrate that a single epigenetic regulator is able to
differentially use its domains to control diverse chromo-
somal targets. The acquisition of the coiled-coil domain of
MOM1 reflects a neofunctionalization of CHD3 proteins,
which allowed MOM1 to broaden its activity and to
provide input into multiple epigenetic pathways.
Structural Basis of MOM1 Function
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CMM2 domain alone retained silencing activity, although with
slightly lower and a more variable TGS efficiency (Figure 1C,
‘‘DN, C’’), which was mainly due to the differences among
independent transgenics in transcript levels for this particular
construct (Figure S1). Therefore, we conclude from this set of
results that CMM2 is necessary and sufficient for the restoration of
TGS at the transgenic GUS locus.
CMM2 domains form an anti-parallel coiled-coil structure
To gain more insight into the function of CMM2, we carried
out structural analyses of this domain. A fragment of the MOM1
protein encompassing the most conserved core of CMM2 was
expressed in bacteria, purified to homogeneity and crystallized
[26]. The best diffracting crystals were obtained with a MOM1
fragment corresponding to amino acid positions 1700 to 1814 (for
experimental details, see [26] and Materials and methods) and a
complete dataset was collected to a maximal resolution of 3.2 A ˚
(Table S1). The structure was solved using seleno-methionine-
containing proteins and the calculated electron density map was of
sufficient quality to trace most parts of the CMM2-containing
protein fragment. A poor electron density map, most likely the
result of the absence of stable secondary structure, prevented us
from building the first 28 as well as the last 3 amino acids of the
CMM2-containing fragment. Consequently, we focused our
attention on the region comprising residues 1729 to 1811, which
corresponds almost exactly to the CMM2 motif (Figure 1B and
Figure 2B).
Figure 1. CMM2 is necessary and sufficient for the TGS activity of MOM1. (A) Schematic representation for MOM1 and miniMOM1. (B) Left,
deletion derivatives of miniMOM1 that were introduced to mom1 L5 plants harboring a transgenic L5 locus encoding ß-glucuronidase [25]. Right,
histochemical GUS staining of cotyledons of seven independent 1-week-old T1 transgenic plants transformed with the corresponding miniMOM1
deletion derivatives. The ‘‘empty vector’’ control corresponds to mom1 L5 transformed with a vector construct without miniMOM1 sequences. (C)
Relative levels of GUS mRNA in T2 plants from 3 independent T1 plants determined by quantitative RT-PCR and normalized to 18S rRNA. The mean of
the ‘‘empty vector’’ control was set to 1. Error bars represent S.E. calculated from 3 experimental sets of 40 to 50 plants each.
doi:10.1371/journal.pgen.1002484.g001
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PLoS Genetics | www.plosgenetics.org 3 February 2012 | Volume 8 | Issue 2 | e1002484Figure 2. Crystal structure of the CMM2 protein fragment. (A) Overall view of the CMM2 coiled-coil structure. The two monomers are
depicted as orange- and green-colored ribbons and the residues forming the interface are shown using the stick representation and colored in blue.
(B) Sequence alignment of the different CMM2 sequences found in plants [24]. At - Arabidopsis thaliana,P t-Populus trichocarpa,V v-Vitis vinifera,O s-
Oryza sativa, Pta - Pinus taeda,Z m-Zea mays,A c-Aquilegia coerulea,M t-Medicago truncatula,S m-Selaginella moellendorffii. The hydrophobic
residues forming the interphase are highlighted in blue (shown in A). The repeated pattern of amino acids is indicated in letters referring to their
positions. Heptad repeats are underlined and hendecad’s repeats are in bold. (C) Axial view of the CMM2 monomer structure together with the radial
net showing the position of each amino acid on a flat surface. The vertical bars on the right side represent change in the a-helical axis direction. The
N-terminus is at the bottom and the C-terminus on top. Amino acids at position A, D and H are highlighted in blue. (D) Hydrophobic interface formed
by the tips of the CMM2 monomers. Symmetry-related CMM2 monomers are depicted as orange- and green-colored ribbons. Amino acids involved in
the interaction are show as sticks and colored according to their atom types (carbon: white, nitrogen: blue, oxygen, red). (E) View of the intra- and
intermolecular salt bridges stabilizing the CMM2 coiled-coil. Amino acids are labeled and depicted as in panel D. Hydrogen bonds are shown as
dashed lines. (F) View along the axis of the CMM2 helices illustrating the difference between the orientation of amino acids in positions e or i and in
positions k or g. (G) Schematic representation of the amino acid positions in the CMM2 anti-parallel coiled-coil structure. Positions forming the
hydrophobic interface are in capital letters. Images were prepared with the program PyMOL (W.L. Delano, The PyMOL Molecular Graphics System,
DeLano Scientific, Palo Alto, CA (2002)).
doi:10.1371/journal.pgen.1002484.g002
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helix. Two such helices form an antiparallel coiled-coil structure
(Figure 2A). The asymmetric unit contains two identical coiled-
coils that further interact via their N- and C-termini to form the
crystal lattice (Figure 2D). Because of their high degree of
structural identity, we describe in more detail only one of the two
coiled coil structures (Figure 2A).
The mutual association of two CMM2 monomers occurs mainly
through a large interface formed by hydrophobic residues
(Figure 2A and 2B). Additional stabilization of the coiled-coil
comes from an intermolecular network of salt bridges established
between glutamate and lysine residues (Figure 2E). In contrast to
the classical coiled-coil structure, CMM2 monomers are not
wound around each other and, therefore, do not generate a left-
handed super-coil. This is different to the superhelical twist
commonly observed when a coiled-coil motif is made of heptad
repeats, where hydrophobic residues in positions A and D are
tightly packed, mimicking knobs into holes [27]. This observation
clearly indicates either that the repeated pattern of hydrophobic
and polar amino-acids residues is not the classical heptad repeat or
that the heptad repeats are separated by insertions, like stutter or
stammer. Such insertions are known to reduce left-hand super-coil
in coiled-coil structures [28]. By comparing the sequences of
CMM2 domains from different plants, it was possible to identify
conserved residues belonging to four consecutive 11 amino-acid
repeats known as a hendecad (Figure 2B; [29]). These hendecad
repeats are preceded by one and followed by three heptad repeats
(Figure 2B). The change in the amino-acid repeat length leads to a
change in coiled-coil handedness, as depicted in Figure 2C, and
results in an almost perfect parallel arrangement of the two helical
CMM2 fragments. As observed for hendecad repeats, amino acids
located at positions A, D and H form the hydrophobic interface
between the two monomers (Figure 2B and 2G).
In general, coiled-coil structures also form higher-order
structures using charged residues located at positions other than
A, D and H (Figure 2B). Consequently, it is possible that CMM2
forms higher-order multimeric structures in vivo. For example,
residues located at positions e and i are solvent exposed and
potentially accessible for other interactions (Figure 2F). In the
context of the crystal lattice, a large surface of interaction is found
between the N- and C- termini of CMM2 domains (Figure 2D).
This interface is composed almost exclusively of hydrophobic
residues and, therefore, may reflect a functional association
(Figure 2D). Subsequently, we mutated several residues thought
to be essential for the formation of higher-order CMM2 structures
to further assess their functional relevance in vivo.
The CMM2 domain forms homodimers in vivo
To examine whether homodimerization of the CMM2 domain
observed in the crystal structure also occurs in vivo, we performed
yeast two-hybrid experiments. We fused the GAL4 activation and
the DNA-binding domains to the CMM2 fragment, (aa 1730 to
1815), co-transformed yeast with the constructs encoding both
fusion proteins, and monitored their interaction using a-galacto-
sidase staining to assess GAL4-regulated gene expression. While a-
galactosidase staining was negative in yeast cells transformed with
the empty vectors or with each single GAL4-CMM2 fusion
construct, co-transformation of the two constructs strongly
activated GAL4 target genes (Figure 3B, construct CMM2).
These results are consistent with homodimerization of CMM2
domains in vivo and clearly indicate that the determined CMM2
coiled-coil structure is also formed in vivo.
Furthermore, based on the crystal structure, the CMM2
monomer not only interacts with itself in a coiled-coil structure,
but each CMM2 coiled-coil contributes to the crystal lattice
through multiple N- and C-termini interactions (Figure 2D). First,
to investigate whether in vivo self-interaction of CMM2 is limited to
the coiled-coil motif, we introduced point mutations aimed at
disrupting the coiled-coil (L1761D and L1765D; CMM2-mut1)
(Figure 3A). There was no a-galactosidase activity in yeast cells co-
transformed with CMM2-mut1 fusion constructs, indicating the
absence of stable interaction between CMM2-mut1 domains
(Figure 3B). In contrast, mutations in the N-terminus (F1736P,
L1737E, and L1740A; CMM2-mut2) and in the C-terminus
(N1799A, I1802E, and L1806P; CMM2-mut3) (Figure 3A), where
the coiled-coil dimers interact with each other to form the crystal
lattice, led to only slightly lower levels of a-galactosidase activity
than with wild-type CMM2 (Figure 3B). In addition, the reduction
in a-galactosidase staining was more pronounced for CMM2-
mut2 than for CMM2-mut3 (Figure 3B). Mutations in CMM2-
mut2 affect two amino acids residing at the end of the coiled-coil
structure that form part of the hydrophobic surface of interaction
between CMM2 monomers. Therefore, their exchange could alter
the coiled-coil structure (Figure 3A), subsequently leading to a
reduction in a-galactosidase staining.
In summary, the yeast two-hybrid results support the notion
that CMM2 monomer association in vivo mostly depends on the
stability of the coiled-coil. The reduced interaction observed with
the CMM2-mut2 fragment indicates that the N-terminus of
CMM2 may also contribute to the self-interaction, albeit to a
lower degree. In addition, the slight reduction in a-galactosidase
staining observed with the CMM2-mut3 construct suggests that
the mutated residues, which were possibly involved in CMM2
multimerization through crystal lattice formation, are only
partially responsible for the stability of the coiled-coil structure.
Multimerization of CMM2 is required for its silencing
activity
The results of structural analyses of CMM2 interactions
supported by yeast two-hybrid results prompted us to determine
whether multimerization of CMM2 is also essential for TGS
activity. To address this question, we transformed mom1L5 plants
with miniMOM1 constructs harboring the same point mutations
examined for their interaction in yeast (Figure 4A). For each
construct, multiple transgenic mom1 L5 plants were generated and
subjected to histochemical staining for GUS activity (eight T1
plants for each construct) (Figure 4A). Subsequently, T2 progeny
of three randomly chosen T1 plants were examined by
quantitative RT-PCR to determine levels of GUS mRNA
(Figure 4B).
All three mutations caused a clear reduction in miniMOM1
silencing activity (Figure 4A and 4B). Importantly, the degree of
TGS release correlated well with results obtained in the yeast two-
hybrid assays. In both experiments, CMM2-mut1 had the
strongest influence, practically abolishing the TGS activity of
CMM2 (Figure 4A and 4B). In contrast, CMM2-mut2 retained
partial TGS activity, although significantly lower than that of the
intact CMM2 fragment (Figure 4A and 4B). In both cases, the
decrease in TGS activity was not due to reduced protein stability
(Figure S2). Finally, the CMM2-mut3 had TGS activity
comparable to the original CMM2, as revealed by quantitative
RT-PCR (Figure 4B), but displayed increased variability in the
degree of TGS among individuals examined by histochemical
GUS assays (Figure 4A). Obviously, this variability may reflect
differences between the eight independent transgenic events,
perhaps further exaggerated by a GUS protein half-life longer
than that of GUS mRNA. Nevertheless, all the above results are
consistent with the notion that CMM2 homodimerization,
Structural Basis of MOM1 Function
PLoS Genetics | www.plosgenetics.org 5 February 2012 | Volume 8 | Issue 2 | e1002484Figure 3. Intermolecular interaction of CMM2 domains in vivo. (A) Radial net representation of the CMM2 sequence with the mutated amino
acids of the CMM2-mut1, -mut2 and -mut3 constructs indicated in red, yellow and orange, respectively. On each side of the radial net, the CMM2
coiled-coil structure is shown as green- and orange ribbons with the targeted amino acids displayed as sticks surrounded with a mesh surface
(colored as described above). (B) Schematic presentation of vectors used in the yeast two-hybrid experiments (left) and a-galactosidase staining of
yeast co-transformed with corresponding protein fusions (right). ‘‘X’’ on the construct models represents approximate positions of mutations (colored
according to A). The ‘‘empty vector’’ contained only GAL4-AD and GAL4-BD.
doi:10.1371/journal.pgen.1002484.g003
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prerequisite for TGS activity.
The target-specific contribution of CMM2 to MOM1-
mediated TGS
Having demonstrated that a short CMM2 domain and its
intermolecular interactions are essential for TGS at the GUS
transgenic locus, we next extended our analysis to endogenous
genes normally regulated by MOM1. MOM1 targets have been
assigned to three different classes based on the degree of MOM1
cooperation with RdDM [22,23]. At the SDC locus (At2g17690),
TGS requires both MOM1 and RdDM acting epistatically
[22,23]. At the APUM9 locus (At1g35730) and at various transgenic
loci, TGS requires MOM1 and RdDM acting independently [23].
Finally, at the MULE-F19G14 (At2g15810), At3g42719 and
At2g11780 loci, TGS control requires almost exclusively MOM1,
although marginal contribution of RdDM cannot be ruled out
[22,23].
In transgenic complementation assays, we determined the
transcripts levels for each of the loci described above in wild-
type Arabidopsis, in the mom1 mutant and in mom1 strains
complemented by miniMOM1 (Figure 5, ‘‘empty vector in
WT’’, ‘‘empty vector in mom1’’ and ‘‘miniMOM1 in mom1’’,
respectively) and also calculated miniMOM1 silencing efficiency
for each chromosomal target (Figure S3). miniMOM1 was clearly
more effective in silencing SDC, APUM9 and the transgenic GUS
locus (targets requiring MOM1 and RdDM for TGS) than for
silencing of MULE-F19G14, At3g42719 and At2g11780 (mostly
Figure 4. Multimerization of CMM2 domains are crucial for TGS activity. (A) Left, schematic models of transgene constructs used for
transgenic complementation assays in mom1 L5 plants. ‘‘X’’ represents mutations colored as in Figure 3. Right, histochemical GUS staining of
cotyledons of eight independent 1-week-old T1 transgenic plants transformed with the corresponding mutant derivatives of miniMOM1. The ‘‘empty
vector’’ control corresponds to mom1 L5 transformed with a vector construct without miniMOM1. (B) Relative levels of GUS mRNA in T2 plants from 3
independent T1 plants determined by quantitative RT-PCR and normalized to 18S rRNA. The mean of the ‘‘empty vector’’ control was set to 1. Error
bars represent S.E. calculated from 3 experimental sets of 40 to 50 plants each.
doi:10.1371/journal.pgen.1002484.g004
Structural Basis of MOM1 Function
PLoS Genetics | www.plosgenetics.org 7 February 2012 | Volume 8 | Issue 2 | e1002484dependent on MOM1 activity for their TGS). Interestingly,
although the above trend was apparent, we observed variations in
silencing efficiency within each category of the loci. For example
transgenic GUS locus was silenced less efficiently than SDC or
APUM9 (Figure 5A). It has been observed that APUM9 and SDC
have clearer RdDM dependence for their silencing [22,23,30]
than this documented for the GUS locus [31]. We noticed also
certain variation in miniMOM1 silencing efficiency in the second
category of loci (MULE-F19G14, At3g42719 and At2g11780),
which could also reflect marginal but variable contribution of
RdDM to their TGS (Figure 5B). Nevertheless, despite of the
observed and somehow expected variations in the functional
overlaps between MOM1 and RdDM mediated TGS pathways,
our results suggest that miniMOM1, and therefore the CMM2
domain, is mostly sufficient to replace MOM1 function at
chromosomal targets that are co-regulated by MOM1 and
RdDM, but does this much less efficient at targets regulated by
MOM1, mostly independently of RdDM.
The necessity and sufficiency of CMM2 for miniMOM1 activity
at these various chromosomal targets was further assessed by
transgenic complementation with miniMOM1 deletion constructs.
CMM2 was seen to be essential for TGS regulation at two loci co-
regulated by RdDM (Figure S4). Moreover, we examined whether
TGS at these loci requires CMM2 multimerization (Figure 6).
Consistent with the TGS regulation observed at the transgenic
Figure 5. CMM2 acts selectively on MOM1-regulated TGS
targets. Relative levels of mRNAs in T2 plants of various MOM1 target
loci determined by quantitative RT-PCR and normalized to 18S rRNA.
The targets regulated by MOM1 co-operatively with RdDM (A) and
largely by MOM1 only (B) were investigated. These T2 plants were
delivered from 3 independent T1 plants. The mean of ‘‘empty vector in
mom1’’ was set to 1. The mean values of relative expression are
indicated above columns. Error bars represent S.E. calculated from 3
experimental sets of 40 to 50 plants each.
doi:10.1371/journal.pgen.1002484.g005
Figure 6. Multimerization of CMM2 domains is crucial for TGS
activity at various chromosomal loci. Relative levels of mRNAs in
T2 plants of various MOM1 target loci determined by quantitative RT-
PCR and normalized to 18S rRNA. These T2 plants were delivered from 3
independent T1 plants. The mean of ‘‘empty vector in mom1’’ was set
to 1. Error bars represent S.E. calculated from 3 experimental sets of 40
to 50 plants each.
doi:10.1371/journal.pgen.1002484.g006
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displayed a significant reduction in silencing activity also at SDC
and APUM9. However, at MULE-F19G14, the CMM2 mutations
had only a marginal effect due to the generally limited role of
CMM2 in silencing this locus (Figure 6).
Discussion
MOM1, as a large nuclear protein involved in chromatin-
mediated transcriptional regulation, is able to shift transcriptional
states largely independently of changes in epigenetic marks
[17,19,20]. It was shown previously that a short fragment of
MOM1 of 198 amino acids (miniMOM1) containing a CMM2
domain of 82 amino acids (1734 to 1815) is necessary and
sufficient to control transcriptional suppression at a transgenic
locus and at endogenous pericentromeric sequences derived from
Athila retroelements [24]. These results indicated that CMM2,
which is conserved in all vascular plants, is essential for MOM1-
mediated TGS. To gain further insight into molecular mecha-
nisms associated with CMM2 activity in silencing, we performed
structural and functional analyses. An important prerequisite for
such studies was an assessment of CMM2 silencing activity in the
absence of its flanking sequences. Interestingly, deletions of either
the N or C terminal flank had no influence on the TGS activity of
miniMOM1; however, after simultaneous deletion of both flanks,
the silencing activity of the CMM2 construct was reduced by
approximately 20% due to variable transcript levels in transgenic
plants seen for this particular construct. Hence, the majority of
miniMOM1 silencing activity can be clearly attributed to CMM2.
However, each of its flanks can act to support CMM2-mediated
TGS by stabilization of transgenic expression or possibly further
stabilizing CMM2 multimerization discussed below. Since the
central role of CMM2 in miniMOM1-mediated regulation of
TGS is apparent, we decided to elucidate its structural and
functional features.
The CMM2 structure presented here constitutes the first
example of an anti-parallel coiled-coil containing multiple
hendecad repeats. Although three structures of hendecad-based
coiled-coil are reported in the literature (cytoskeleton protein [29];
tetrabrachion [32]; H+/ATPASE [33]), available knowledge is
rather limited about the oligomeric properties of hendecad-
containing coiled-coil structures as compared to heptad-based
coiled-coils. The CMM2 structure thus provides additional and
important information on this particular type of coiled-coil.
Hendecad-containing structures form dimers or tetramers. The
CMM2 fragment forms dimeric coiled-coils with extensive
hydrogen bonds or salt bridges mediating inter-chain contacts
via residues at positions g and k. This is in marked contrast to the
recently reported parallel hendecad-based coiled-coil structure of
the peripheral stalk of the H
+-ATPase/synthase, where inter-chain
contacts are mostly due to residues at positions d, e and i [33].
Importantly, the formation of a coiled-coil by CMM2 domains
seems to occur in vivo, where it is essential for TGS activity. Since
residues at positions e and i of CMM2 are not involved in inter-
chain contacts, they may mediate interactions with MOM1
partners in vivo. This raises the possibility that the CMM2
coiled-coil structure is a ‘‘landing platform’’ for additional factors,
although such additional interaction partners have not yet been
described. This resembles the recently reported homodimerization
of the coiled-coil domain of barley MLA protein, which belongs to
the family of R proteins involved in cellular responses to pathogen
infection [34]. It has been shown that homodimerization of only
the coiled-coil domains of MLA can activate programmed cell
death, which is essential for the defense response to pathogens.
This homodimerization of MLA coiled-coil domains provides a
binding platform for WRKY transcription factors and it was
proposed that homodimers of MLA coiled-coil domains constitute
the minimal R protein unit able to initiate the cell death response
[34]. Similarly, dimerization of the CMM2 of MOM1 is necessary
and sufficient for its TGS activity and mutations altering this
process abolish TGS mediated by CMM2. It is also possible that
the multimerization of the CMM2 domain, either via the coiled-
coil structure or via the N- and C-termini could contribute to its
interaction with other proteins. The functional data obtained for
CMM2 structure-guided mutants will make it possible to design an
optimized strategy for revealing further proteins with a binding
affinity specific for the CMM2 coiled-coil domain and subse-
quently to assess their contributions to MOM1-mediated TGS.
Moreover, the charged amino acids located at positions e and i
may also be involved in nucleic acid recognition. Further
experiments are needed to determine the veracity of these clues.
In a forward genetic screen for modifiers of the silencing
properties of the mom1 mutant, a mutation in the RdDM
component, which is a plant-specific RNA polymerase V (nrpe1),
was isolated as an enhancer of TGS release observed in mom1 [23].
This provided evidence for the functional interaction of silencing
mechanisms mediated by MOM1 and RdDM pathways. More-
over, the results from previous studies [24] and those presented
here show that miniMOM1-mediated TGS at chromosomal
targets co-regulated by MOM1 and RdDM (transgenic locus,
SDC, APUMP9) is very effective. These observations substantiated
the evidence for a critical role of the CMM2 domain in this
process. Surprisingly, however, with the chromosomal targets
MULE-F19G14, At3g42719, and At2g11780 for which TGS seems
to be regulated by MOM1 without significant RdDM assistance,
miniMOM1 was not able to initiate and/or maintain TGS. These
results imply that, in addition to CMM2, further domains of
MOM1 are essential for the establishment and the maintenance of
TGS at MULE-F19G14, At3g42719, At2g11780 and possibly other
loci that are controlled by MOM1 in a fashion largely independent
of RdDM. The slight reduction in MULE-F19G14 transcript levels
observed upon introduction of miniMOM1 can be explained by a
minor contribution of RdDM to MULE-F19G14 silencing, as
revealed by slight release of its silencing in the nrpd1 mutant
(mutated in plant specific Pol IV) [22], in which the biogenesis of
siRNAs required for RdDM is impaired. Similarly, the reduction
in the At3g42719 and At2g11780 transcript levels may be explained
by a minor contribution of RdDM to their TGS.
As a general conclusion, we propose that CMM2, although it
seems to be necessary for MOM1-mediated TGS, is only sufficient
for silencing at loci that are evidently co-regulated by MOM1 and
RdDM. In other words, the cooperation of MOM1 with RdDM,
which was initially revealed by their genetic interaction [23], seems
to be largely mediated by CMM2 homodimerization. While
MOM1 orthologs containing CMM2 are present in vascular
plants, the RdDM-related pathway is more extensive and has also
been documented in mosses [35]. This suggests that the two TGS
mechanisms evolved independently and that MOM1, with its
CMM2-mediated silencing activity, augmented the RdDM
pathway at the onset of the vascular plants lineage. This hypothesis
is further supported by the observation that TGS at certain loci
remains under RdDM control in a MOM1-independent fashion
[23]. The question of why only some RdDM targets require
MOM1, and especially the CMM2 domain, to support RdDM-
mediated TGS remains open.
As presented here, the results suggest that MOM1 can use
distinct and target-specific TGS mechanisms that can be assigned
to its structural features. This is consistent with previous genetic
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of MOM1 [22,23]. Importantly, here we are able to relate MOM1
silencing activity to a short but essential CMM2 domain and to its
ability to form a hendecad-based coiled-coil involved in intermo-
lecular interactions. This very short CMM2 protein fragment
seems to be a dimeric platform especially critical for the
cooperation of MOM1 with the RdDM pathway.
Materials and Methods
Plant material
All plants used were in the Columbia accession. L5 GUS line
and mom1-3 (SALK_141293) were described before [25,36].
Transgenic strains were obtained by Agrobacterium containing a
modified pGWB-NB1 binary vector which is a prototype of
pGWB601 [37] supplemented with a BAR selectable gene. The
fragment containing approximately 2 kb of MOM1 promoter
linked to a coding sequence of miniMOM1 [24] was subcloned
into pDONR-zeo by Gateway BP reaction (Life Technologies).
miniMOM1 deletion and mutant derivatives were obtained by
inverse PCR using a KOD hotstart DNA polymerase (Novagen),
and subcloned by LR reaction (Life Technologies) into a pGWB-
NB1 binary vector. The constructs were transformed into mom1-3
L5 plants using floral dip methods [38].
Histochemical GUS analyses
Cotyledons of 7-day-old seedlings (one cotyledon per plant)
were vacuum infiltrated for 30 min with X-Gluc solution [400 mg/
ml 5-bromo-4-chloro-3-indolyl-b-glucuronide, 3 mM K3Fe(CN)6,
3m MK 4Fe(CN)6, 10 mM ethylenediamine tetraacetic acid and
100 mM Na-phosphate buffer, pH 7.0] and incubated 2 over-
nights at 37uC. The chlorophyll was removed by extraction in
70% ethanol.
Quantitative RT–PCR and Western blot analyses
Total cellular RNA was isolated from 7-day-old seedlings using
the TRI reagent (Sigma) according to the manufacturer’s
instructions. After RQ1 DNase treatment (Promega), the first-
strand cDNA was synthesized with Superscript VILO cDNA
synthesize kit (Life Technologies). Real time PCR reactions were
performed with fluorescent probes using QuantiFast Multiplex
PCR kit (Qiagen) in ABI7900FT (Life technologies). GUS and
APUM9 transcripts were subjected to duplex analyses using two
different fluorescent dyes, while SDC, MULE-F19G14, At3g42719
and At2g11780 RNAs were detected by separate reactions with
simplex analyses for each dye. Amounts of mRNA were calculated
by subtraction of the values obtained without reverse transcriptase
reaction and normalized with respect to the amount of 18S rRNA.
Primers and probes used for RT-PCR were designed with Primer
Express program (Life technology) and their sequences are listed in
Table S2.
Yeast two-hybrid assay
Yeast two-hybrid assay was performed by Matchmaker Gold
Yeast Two-Hybrid System (Clontech) according to the manufac-
turer’s instruction.
Western blotting
Western blotting was performed as described in [24].
Expression, purification, and crystallization
A construct encoding a part of the MOM1 protein (aa 1700
to 1814) was overexpressed in E. coli and the protein was
purified as previously reported [26], concentrated to ,15 to
18 mg/ml and crystallized at 4uC via hanging drop vapor
diffusion, with initial crystals forming in 0.1 M Tris pH 8.5,
0.3 M magnesium formate dihydrate buffer. Crystallization was
further optimized and, after stabilization in similar conditions,
was supplemented by 20% ethylene glycol. The crystals were
flash frozen in liquid nitrogen and their diffraction properties
measured previously described [26]. A seleno-methionine-
containing protein was produced using E. coli strain 834, which
is auxotrophic for methionine, in minimal medium supplement-
ed with seleno-methionine. Crystals of proteins with seleno-
methionine grew in conditions similar to those for the native
protein and were subjected to a similar stabilization procedure
before freezing.
Data collection and processing
Diffraction data were collected at the European Synchrotron
Radiation Facility (ESRF, Grenoble, France) on the beam lines
ID23-1, ID29 and ID14-4. A complete data set using native
protein crystal was collected at a maximum resolution of 3.2 A ˚.A
further data set was collected at the selenium edge with a
selenium-containing protein crystal. This crystal diffracted to
,3.5 A ˚ resolution. A Single Anomalous Dispersion phasing
procedure was used to solve the phase problem using the selenium
as heavy atoms. Briefly, the 8 seleno-methionines were located by
the program SHELXD using the measured anomalous signals
[39–41]. The sites were subsequently injected into the experimen-
tal SAD phasing procedure as defined in SHARP [42]. Density
modification was then used to improve the initial set of phases
[43]. Long tubes of electron density were readily visible in the
calculated electron density map and the initial model was built
using the program Coot [44] with an alanine-only model. The
protein register was defined based on the position of the
methionine residues. Several rounds of refinement/rebuilding
were done iteratively using the PHENIX software [45]. All the
built residues are in the favored and allowed regions of the
Ramachandran plot. Residues 1700 to 1728 and 1811 to 1814 are
disordered or very poorly ordered in every CMM2 molecules. The
protein coordinates have been deposited in the Protein Databank
with the PDB code 3VEM.
Accession numbers
AtMOM1 (AAF73381); PtMOM1 (EEE94860); VvMOM1
(CBI16337); OsMOM1 (EEE64938); PtaMOM1 (Co364249);
ZmMOM1 (GRMZM2G47428); AcMOM1 (AcoGoldSmith_
v1.001036m); MtMOM1 (fpc265_22); SmMOM1 (EFJ29853).
Supporting Information
Figure S1 (A) Relative levels of GUS mRNA. Levels of GUS
mRNA determined by quantitative RT-PCR and normalized to
18S rRNA. For each construct 40-50 progeny plants of
independent T1 transgenics (numbers 1, 2, and 3, which are
corresponding with those of Figure 1B) transformed with deletion
derivatives of miniMOM1 were used for RNA isolation. Error
bars represent S.E. calculated from 2 technical replicates. The
mean of technical replicates of T1 plant no. 1 transformed with
‘‘empty vector’’ was set to 1. (B) Transcript levels of various
miniMOM1 derivatives. Top, semi-quantitative RT-PCR revealing
the levels of miniMOM1 transcripts and its deletion derivatives in
the same RNA used in (A). Bottom, ACT2 transcripts as internal
controls. RT+ and RT2, reactions with presence or absence of
reverse-transcriptase, respectively.
(TIF)
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expressed. (A) Relative levels of GUS mRNA determined by
quantitative RT-PCR and normalized to 18S rRNA. For each
construct 40–50 progeny plants of independent T1 transgenics (A
and B) transformed with mutant derivatives of miniMOM1 were
used for RNA isolation. Error bars represent S.E. calculated from
2 technical replicates. The mean of technical replicates of T1 plant
B transformed with ‘‘empty vector’’ was set to 1. (B) Top, western
blot revealing the levels of HA-tagged miniMOM1 and its mutant
derivatives in 1-week-old T2 plants whose siblings were used in
(A). Bottom, Coomassie Brilliant Blue-stained parallel gel.
(TIF)
Figure S3 Relative silencing efficiency (SE) of miniMOM1-
mediated TGS at various chromosomal targets. (A) Silencing
efficiency at MOM1 targets regulated in cooperation with RdDM
and (B) silencing efficiency at MOM1 targets regulated mostly by
MOM1 alone. Columns marked (1) ‘‘SE in WT ‘‘ (set to 100%),
and columns marked (2) ‘‘SE in mom1 complemented by
miniMOM1’’ were calculated as ratios of the relative expression
in ‘‘empty vector in WT’’ and in ‘‘miniMOM1 in mom1’’ (Figure 5).
The values of ‘‘SE in mom1 complemented by miniMOM1’’ are
shown above columns.
(TIF)
Figure S4 TGS activity of the CMM2 domain for chromosomal
targets. Relative levels of mRNAs in T2 plants of various MOM1
target loci determined by quantitative RT-PCR and normalized to
18S rRNA. These T2 plants were delivered from 3 independent
T1 plants. The mean of ‘‘empty vector in mom1’’ was set to 1.
Error bars represent S.E. calculated from 3 experimental sets of 40
to 50 plants each.
(TIF)
Table S1 Crystallographic data collection and refinement
statistics.
(DOC)
Table S2 List for primers and probes used for RT–PCR.
(DOC)
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